Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University
Chief of Hematology/Oncology
Medical Director of Memorial Cancer Institute
Lung Cancer Video Library Spanish - Raez - New Targeted Therapies for NSCLC Waiting for Approval (RET – Loxo 292 and Blu667)
dbrock
Lung Cancer Video Library Spanish - Raez - NUEVAS TERAPIAS DIRGIDAS PARA CANCER DE PULMON - RET (Loxo 292 and Blu667)
Image
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community.
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr. Luis Raez nos brinda información actualizada. En este video, el Dr. Raez analiza las nuevas terapias dirigidas para el NSCLC a la espera de aprobación (RET - Loxo 292 y Blu667).
Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
For this years addition to our Lung Cancer Video Library produced in Spanish for our Latino Community, Dr. Luis Raez provides us with up to date information. In this video, Dr. Raez discusses new targeted therapies for NSCLC waiting for approval (RET – Loxo 292 and Blu667).
To join the conversation, visit https://cancergrace.org/forum.
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...